For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250701:nRSA1620Pa&default-theme=true
RNS Number : 1620P Geiger Counter Ltd 01 July 2025
THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE
PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH
IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS
AMENDED
Geiger Counter Limited (or the "Company")
1 July 2025
Entry into Standstill Agreement
The Company is pleased to announce that, following constructive engagement
with Saba Capital Management, L.P. ("Saba"), it has agreed the terms of a
Standstill Agreement.
Under the terms of the Standstill Agreement, Saba has agreed, amongst other
things: that Saba shall not, and shall procure that its affiliates shall not,
during the Standstill Period (i) require the Board to convene a general
meeting of the Company pursuant to Jersey law; or (ii) exercise any voting
rights available to remove, or publicly propose the removal of, any member of
the Board. In addition, until the expiry or termination of the Standstill
Period, Saba shall not, and shall use its reasonable endeavours to procure
that its affiliates shall not, vote against the recommendation of the Board on
specified ordinary course resolutions proposed at a general meeting or annual
general meeting of the Company.
The Standstill Agreement shall have effect until the earliest of (i) the
Company's AGM in 2028 or (ii) any earlier winding up, liquidation or voluntary
corporate reconstruction of the shares and assets of the Company.
Enquiries
Manulife | CQS Investment Management Craig Cleland T: +44 (0) 20 7201 5368
Cavendish Capital Markets Limited Tunga Chigovanyika T: +44 (0) 20 7397 1915
(Corporate Finance)
Daniel Balabanoff / Pauline Tribe (Sales) T: +44 (0) 20 7220 0500
R&H Fund Services (Jersey) Limited Jane De Barros T :+44 (0) 1534 825 259
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END AGREAKXFEANSEEA